Oramed Pharmaceuticals Inc. (ORMP) stock
ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.87−0.03 (-0.77%)
Close on Nov 17, 2026Market cap $160.98MP/E 0.9Yield 6.46%
Oramed Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Oramed Pharmaceuticals's price to book ratio was 0.8× on Apr 30, 2026, against 0.6× a year earlier. Over the last 5 years it ranged from 0.5× to 9.8×, with a median of 0.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 0.8× | +0.2 |
| 2025 | Dec 31, 2025 | 0.6× | −0.0 |
| 2024 | Dec 31, 2024 | 0.6× | −0.0 |
| 2023 | Dec 29, 2023 | 0.6× | −3.0 |
| 2022 | Dec 30, 2022 | 3.7× | −0.7 |
| 2021 | Dec 31, 2021 | 4.4× | +1.3 |
| 2020 | Dec 31, 2020 | 3.1× | −1.6 |
| 2019 | Dec 31, 2019 | 4.6× | +2.9 |
| 2018 | Dec 31, 2018 | 1.7× | −4.7 |
| 2017 | Dec 29, 2017 | 6.4× | +3.3 |
| 2016 | Dec 30, 2016 | 3.1× | −0.9 |
| 2015 | Dec 31, 2015 | 4.0× | +1.8 |
| 2014 | Dec 31, 2014 | 2.2× | −12.8 |
| 2013 | Dec 31, 2013 | 15.1× | +8.1 |
| 2012 | Dec 31, 2012 | 7.0× | +1.7 |
| 2011 | Dec 30, 2011 | 5.3× | – |
See a number that looks wrong?